AAAAAA
Results:
1-17
|
Results: 17
Authors:
VONLANTHEN S
HEIGHWAY J
TSCHAN MP
BORNER MM
ALTERMATT HJ
KAPPELER A
TOBLER A
FEY MF
THATCHER N
YARBROUGH WG
BETTICHER D
Citation: S. Vonlanthen et al., EXPRESSION OF P16INK4A P16-ALPHA AND P19ARF/P16-BETA IS FREQUENTLY ALTERED IN NONSMALL CELL LUNG-CANCER AND CORRELATES WITH P53 OVEREXPRESSION/, Oncogene, 17(21), 1998, pp. 2779-2785
Authors:
BORNER MM
CASTIGLIONE M
BACCHI M
WEBER W
HERRMANN R
FEY MF
PAGANI O
LEYVRAZ S
MORANT R
PESTALOZZI B
HANSELMANN S
GOLDHIRSCH A
Citation: Mm. Borner et al., THE IMPACT OF ADDING LOW-DOSE LEUCOVORIN TO MONTHLY 5-FLUOROURACIL INADVANCED COLORECTAL-CARCINOMA - RESULTS OF A PHASE-III TRIAL, Annals of oncology, 9(5), 1998, pp. 535-541
Authors:
ROTH AD
MAIBACH R
MORANT R
PAGANI O
DEBRAUD F
BORNER MM
STUPP R
HERRMANN R
FAZIO N
SESSA C
GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY, Annals of oncology, 9, 1998, pp. 232-232
Authors:
BORNER MM
MAUER CA
FRIESS H
LUDWIG CU
BUCHLER MW
FEY MF
Citation: Mm. Borner et al., GEMCITABINE (GEM) AND CONTINUOUS-INFUSION FLUOROURACIL (CIF) - A PHASE-II STUDY IN ADVANCED PANCREATIC-CANCER (APC), Annals of oncology, 9, 1998, pp. 241-241
Authors:
MAURER CA
BORNER MM
LAUFFER J
FRIESS H
ZGRAGGEN K
TRILLER J
BUCHLER MW
Citation: Ca. Maurer et al., CELIAC AXIS INFUSION CHEMOTHERAPY IN ADVANCED NONRESECTABLE PANCREATIC-CANCER, International journal of pancreatology, 23(3), 1998, pp. 181-186
Authors:
DIXON SC
SORIANO BJ
LUSH RM
BORNER MM
FIGG WD
Citation: Sc. Dixon et al., APOPTOSIS - ITS ROLE IN THE DEVELOPMENT OF MALIGNANCIES AND ITS POTENTIAL AS A NOVEL THERAPEUTIC TARGET, The Annals of pharmacotherapy, 31(1), 1997, pp. 76-82
Authors:
ROTH AD
MAIBACH R
MARTINELLI G
FAZIO N
PAGANI O
MORANT R
BORNER MM
HERRMANN R
HONEGGER HP
CAVALLI F
ALBERTO P
CASTIGLIONE M
GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN (TC) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PROMISING DRUG-COMBINATION, European journal of cancer, 33, 1997, pp. 1245-1245
Authors:
BORNER MM
JONCOURT F
HOTZ MA
Citation: Mm. Borner et al., TYPE OF INDUCING SIGNAL REGULATES TRANSACTIVATION BY P53, Biochimica et biophysica acta. Molecular cell research, 1358(3), 1997, pp. 314-320
Authors:
BORNER MM
JONCOURT F
HOTZ MA
Citation: Mm. Borner et al., SIMILARITY OF APOPTOSIS INDUCTION BY 2-CHLORODEOXYADENOSINE AND CISPLATIN IN HUMAN MONONUCLEAR BLOOD-CELLS, British Journal of Cancer, 76(11), 1997, pp. 1448-1454
Authors:
BORNER MM
BACCHI M
CASTIGLIONE M
Citation: Mm. Borner et al., POSSIBLE DELETERIOUS EFFECT OF TAMOXIFEN IN PREMENOPAUSAL WOMEN WITH LOCOREGIONAL RECURRENCE OF BREAST-CANCER, European journal of cancer, 32A(12), 1996, pp. 2173-2176
Authors:
SINHA BK
YAMAZAKI H
ELIOT HM
SCHNEIDER E
BORNER MM
OCONNOR PM
Citation: Bk. Sinha et al., RELATIONSHIPS BETWEEN PROTOONCOGENE EXPRESSION AND APOPTOSIS INDUCED BY ANTICANCER DRUGS IN HUMAN PROSTATE TUMOR-CELLS, Biochimica et biophysica acta. Molecular basis of disease, 1270(1), 1995, pp. 12-18
Authors:
ELIOT HE
BORNER MM
SINHA BK
Citation: He. Eliot et al., DIFFERENTIAL ONCOGENE EXPRESSION AND SUSCEPTIBILITY TO APOPTOSIS IN THE HUMAN LEUKEMIA HL-60 CELL-LINES - IMPLICATIONS FOR ETOPOSIDE RESISTANCE, Anticancer research, 15(3), 1995, pp. 729-733
Authors:
BORNER MM
MYERS CE
SARTOR O
SEI Y
TOKO T
TREPEL JB
SCHNEIDER E
Citation: Mm. Borner et al., DRUG-INDUCED APOPTOSIS IS NOT NECESSARILY DEPENDENT ON MACROMOLECULAR-SYNTHESIS OR PROLIFERATION IN THE P53-NEGATIVE HUMAN PROSTATE-CANCER CELL-LINE PC-3, Cancer research, 55(10), 1995, pp. 2122-2128
Authors:
SEI Y
VONLUBITZ DKJE
BASILE AS
BORNER MM
LIN RCS
SKOLNICK P
FOSSOM LH
Citation: Y. Sei et al., INTERNUCLEOSOMAL DNA FRAGMENTATION IN GERBIL HIPPOCAMPUS FOLLOWING FOREBRAIN ISCHEMIA, Neuroscience letters, 171(1-2), 1994, pp. 179-182
Authors:
BORNER MM
SCHNEIDER E
PIRNIA F
SARTOR O
TREPEL JB
MYERS CE
Citation: Mm. Borner et al., THE DETERGENT TRITON X-100 INDUCES A DEATH PATTERN IN HUMAN CARCINOMACELL-LINES THAT RESEMBLES CYTOTOXIC LYMPHOCYTE-INDUCED APOPTOSIS, FEBS letters, 353(2), 1994, pp. 129-132
Authors:
BORNER MM
SARTOR O
Citation: Mm. Borner et O. Sartor, RESPONSE TO MORE IS NOT ALWAYS BETTER - A CASE FOR LOW-DOSE LEUCOVORIN - REPLY, Journal of clinical oncology, 11(7), 1993, pp. 1435-1435
Authors:
BORNER MM
KNEER J
CREVOISIER C
BRUNNER KW
CERNY T
Citation: Mm. Borner et al., BIOAVAILABILITY AND FEASIBILITY OF SUBCUTANEOUS 5-FLUOROURACIL, British Journal of Cancer, 68(3), 1993, pp. 537-539
Risultati:
1-17
|